Inicio Área de profesionales Artículos publicados Weekly Docetaxel as Neoadjuvant Chemotherapy for Stage II and III Breast Cancer. Efficacy and Correlation with Biological Markers in a Phase II, Multicenter Study

Weekly Docetaxel as Neoadjuvant Chemotherapy for Stage II and III Breast Cancer. Efficacy and Correlation with Biological Markers in a Phase II, Multicenter Study

Correo electrónico Imprimir

Laura G. Estévez, Jose Miguel Cuevas, Antonio Anton, Jesús Florián, Jose Manuel López-Vega, Amalia Velasco, Francisco Lobo, Ana Herrero and Jose Fortes. Weekly Docetaxel as Neoadjuvant Chemotherapy for Stage II and III Breast Cancer. Efficacy and Correlation with Biological Markers in a Phase II, Multicenter Study. Clinical Cancer Research 2003; 9:686-692.

Para más información vaya al siguiente enlace:

http://www.ncbi.nlm.nih.gov/pubmed/12576436